GEN1047 for Solid Tumors - First in Human (FIH) Trial
Genmab
Genmab
Genmab
Accent Therapeutics
Pheon Therapeutics
Seagen Inc.
Fusion Pharmaceuticals Inc.
Blueprint Medicines Corporation
Alaunos Therapeutics
Artios Pharma Ltd
Tempus AI
Incyte Corporation
NiKang Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Pfizer
Bio-Thera Solutions
Alaunos Therapeutics
Numab Therapeutics AG
Hutchmed
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Pfizer
Pfizer
Black Diamond Therapeutics, Inc.
Seagen Inc.
Seagen Inc.
Deciphera Pharmaceuticals, LLC
Aminex Therapeutics, Inc.
Five Prime Therapeutics, Inc.
Elucida Oncology
Nurix Therapeutics, Inc.
Haihe Biopharma Co., Ltd.
pharmaand GmbH
Fate Therapeutics
Incyte Corporation
Xenetic Biosciences, Inc.
Zai Lab (Hong Kong), Ltd.
Novartis
PharmaMar
Incyte Corporation
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Advenchen Laboratories, LLC
AbbVie
Ipsen
Pfizer
R-Pharm
Novartis
Otsuka Novel Products GmbH
CytoCore, Inc.
Cook Group Incorporated
Calando Pharmaceuticals